Carbamazepine
- Product NDC
- 51079-385
- 11-digit product format
- 510790385
- Labeler code
- 51079
- Product ID
- 51079-385_b7006dd3-787e-3ed2-e053-2995a90a491d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA070541
- Marketing category
- ANDA
- Marketing start
- 1995-09-28
- Marketing end
- 2021-02-28
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51079-385-20 | 51079038520 | 100 BLISTER PACK in 1 CARTON (51079-385-20) > 1 TABLET in 1 BLISTER PACK (51079-385-01) | 100 blister pack | 1995-09-28 | 2021-02-28 | No | No | Current |